Smoking-attributable mortality and expected years of life lost in Canada 2002: Conclusions for prevention and policy

Chronic Diseases in Canada

Volumn 27, Issue 4, 2006, Pages 154-162

  Baliunas, Dolly ^a,b   Patra, Jayadeep ^a,b   Rehm, Jürgen ^a,b,c   Popova, Svetlana ^a,b   Kaiserman, Murray ^d   Taylor, Benjamin ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

^d HEALTH CANADA   (Canada)

Author keywords

Canada; Expected years of life lost (EYLL); Mortality; Relative risks (RR); Smoking attributable fractions (SAF)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLADDER CANCER; CANADA; CEREBROVASCULAR DISEASE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; ESOPHAGUS CANCER; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; INFANT; INFLUENZA; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; LARYNX CANCER; LOW BIRTH WEIGHT; LUNG CANCER; MALE; MORTALITY; NEWBORN; OROPHARYNX CANCER; PANCREAS CANCER; PNEUMONIA; SMOKING; STOMACH CANCER; SUDDEN INFANT DEATH SYNDROME; URINARY TRACT CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CANADA; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RESPIRATORY TRACT DISEASES; SEX DISTRIBUTION; SMOKING;

EID: 34548557639     PISSN: 02288699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. 2004. Atlanta, GA., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health.
2. World Health Organization. World Health Report 2002: Reducing risks, promoting health life. 2002. Geneva, World Health Organization.
3. Makomaski Illing EM, Kaiserman MJ. Mortality attributable to tobacco use in Canada and its regions, 1998. Canadian Journal of Public Health 2004; 95:38-44.
4. Sterling TD, Rosenbaum WL, Weindam JJ. Risk attribution and tobacco-related deaths. American Journal of Epidemiology 1993; 138:128-139.
5. Malarcher AM, Schulman J, Epstein LA, Thun MJ, Mowery P, Pierce B et al. Methodological issues in estimating smoking-attributable mortality in the United States. American Journal of Epidemiology 2000; 152:573-584.
6. Gilmore J. Report of smoking in Canada, 1985 to 2001. Catalogue 82F0077XIE. 2002. Ottawa, Statistics Canada.
7. Health Canada. Smoking rates: Canadian Tobacco Use Monitoring Survey. Available at: www.hc-sc.gc.ca/hl-vs/tobac-tabac/res/ news-nouvelles/fs-if/ctums- esutc_e.html. 2005.
8. English DR, Holman CDJ, Milne E, Winter MJ, Hulse GK, Codde G et al. The quantification of drug caused morbidity and mortality in Australia 1995. 1995. Canberra, Australia, Commonwealth Department of Human Services and Health.
9. Statistics Canada. Canadian Community Health Survey, Cycle 2.1. Ottawa, 2003. Catalogue 82M0013XCB
10. Statistics Canada. Causes of death. Ottawa, 2004. Catalogue 84208XIE
11. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. International Journal of Cancer 1997; 72(565):573.
12. Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. International Journal of Cancer 2001; 91:876-887.
13. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes & Control 2003; 14:805-814.
14. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. [Review] [87 refs]. Cancer 2000; 89(3):630-639.
15. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. International Journal of Cancer 2005; 114:101-108.
16. Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes & Control 2001; 12:411-417.
17. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. International Journal of Cancer 2000; 86:289-294.
18. Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia: a meta-analysis. Archives of Internal Medicine 1993; 153:469-475.
19. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. British Medical Journal 1997; 315(7114):973-980.
20. Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Progress in Cardiovascular Diseases 2003; 46:31-38.
21. Single E, Robson L, Xie X, Rehm J. The costs of substance abuse in Canada. 1996. Ottawa, Canadian Centre on Substance Abuse.
22. Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML. Effects of smoking during pregnancy. Five meta-analyses. American Journal of Preventive Medicine 1999; 16(3):208-215.
23. Council of Canadian Fire Marshalls and Fire Commissioners. Fire Losses in Canada Annual Report, 2000. 2003. Council of Canadian Fire Marshals and Fire Commissioners.
24. Walter SD. The estimation of interpretation of attributable risk in health research. Biometrics 1976; 32:829-849.
25. Walter SD. Prevention of multifactorial disease. American Journal of Epidemiology 1980; 112:409-416.
26. Taylor R, Cumming R, Woodward A, Black M. Passive smoking and lung cancer: a cumulative meta-analysis. Australian & New Zealand Journal of Public Health 2001; 25:203-211.
27. de Groh M, Morrison HL. Environmental tobacco smoke and deaths from coronary heart disease in Canada. Chronic Diseases in Canada 2002; 23:13-16.
28. Heloma A, Jaakkola MS. Four-year follow-up of smoke exposure, attitudes and smoking behaviour following enactment of Finland's national smoke-free work-place law. Addiction 2003; 98:1111-1117.
29. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000; 27(1):3-18.
30. Thun MJ, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environmental Health Perspectives 1999; 107:841-846.
31. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease - a meta-analysis of epidemiologic studies. New England Journal of Medicine 1999; 340(12):920-926.
32. WHO Statistical Information System. Discussion paper No.40: Life tables for 191 countries for 2000: data, methods, results. 2000. Geneva, World Health Organization.
33. Mathers CD, Vos A, Lopez AD, Salomon J, Ezzati M. National burden of disease studies: A practical guide. 2nd ed. Geneva: Global Program on Evidence for Health Policy, World Health Organization, 2001.
34. Public Health Agency of Canada. Cancer surveillance on-line. Available at: http:// dsol-smed.phac-aspc.gc.ca/dsol-smed/ cancer/d_time_e.html. 2005.
35. Tanuseputro P, Schult S, Manuel D. Estimating smoking attributable mortality. Canadian Journal of Public Health 2004; 95(2):132.
36. Health Canada. Canadian Tobacco Use Monitoring Survey (CTUMS): Summary of results for 2003. Available at: www.hc-sc.gc. ca/hl-vs/tobac-tabac/research- recherche/ stat/ctums-esutc/2003/index_e.html. 2005.
37. Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. American Journal of Epidemiology 2002; 156:994-1001.
38. Russell LB, Carson JL, Taylor WC, Milan E, Dey A, Jagannathan R. Modelling all-cause mortality: projections of the impact of smoking cessation based on the NHEFS NHANES I Epidemiologic Follow-up Study. American Journal of Public Health 1998; 88:630-636.
39. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. The Cochrane Library 2005; Vol 1.
40. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S et al. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. American Journal of Epidemiology 2005; 161(2):170-179.
41. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung fuction in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. American Journal of Respiratory & Critical Care Medicine 2000; 161:381-390.
42. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. American Journal of Medicine 1999; 106:410-416.